Who we are

A unique team of consultants offering authentic expertise and unparalleled global reach.

Dr Mike Bickerdike, BSc, PhD

Dr Mike Bickerdike is an expert in translating discovery research into commercially viable programmes. An experienced pharmaceutical research manager, his expertise spans over 18 years and includes an extensive background in the research and development of novel drugs. Dr Bickerdike obtained his BSc and PhD degrees in pharmacology in the UK, before undertaking academic research at the Aidekman Neuroscience Research Center in the USA.

In 1996 he joined the UK pharmaceutical company Cerebrus (subsequently Vernalis), where he held several senior positions including Director of Molecular Pharmacology and Project Leader of the company’s flagship research program (successfully partnered with Roche). In 2005, he moved to New Zealand as Director of Research and Preclinical Development for Neuren Pharmaceuticals, a role he held for 8 years. During this time he was responsible for all drug research, safety and toxicology for the company. Dr Bickerdike subsequently founded BioTarget Consulting, a New Zealand based consultancy specialising in biotechnology and pharmaceutical research, development and commercialisation.

Today, Dr Bickerdike specialises in early-stage research evaluation and commercialisation, using his extensive experience in research, research project management, collaborations management and preclinical development leadership. Dr Bickerdike particularly excels in the commercial assessment of pharmaceutical and biotechnology innovations, and in addition to his work with Life Science New Zealand and BioTarget Consulting, is Chairman of the ‘Return on Science’ Biotech and Life Sciences Investment Committee.

Areas of Expertise

  • Commercial Assessment of Pharmaceutical & Biotechnology Innovations
  • Advice on Developmental Strategies
  • Discovery Research Project Management
  • Manuscript & Grant Application
  • Pharmaceutical Regulatory Advice: IND Submissions, ICH Requirements, CMC & Safety Documentation
  • Preclinical Development Planning & Execution
  • Preclinical Safety & Toxicology Advice & Management
  • Requirements to Support Pharmaceutical Clinical Trials